|
Post by kc on Feb 13, 2017 11:37:28 GMT -5
Always been stumped by MNKD foundation not selling. They understand the potential of Afrezza being a home run if they can wait it out. As I said earlier in this thread, the foundation probably has other holdings besides MannKind stock.
|
|
|
Post by kc on Feb 13, 2017 11:01:35 GMT -5
They probably changed the meeting to give as many of the shareholders the opportunity to respond and vote their shares. Most Proxies that companies send out sadly go un opened and not voted. since this is a very serious vote you also read that they hired a 3rd party company to assist in contacting shareholders to vote. They need to make sure all votes are accounted for and they need the time to make it happen. The 24th was a tough date to get it all accomplished by with being able to send the documents out and get responses. If would be better if all the shareholders just voted their shares online vs waiting for the proxies to arrive in the mail.
|
|
|
Post by kc on Feb 13, 2017 10:01:44 GMT -5
Al Mann / Al Mann trust has owned 42%. There is no buying more. Please don't believe that this trust is some magic pool of money. The trust owned shares of MNKD. The shares are worth approx. .50cents each. The Billions that Al Mann and the Trust had ARE GONE! It's sad and disappointing for the Trust for sure. Just don't want you to believe that the Trust will be MNKD's savior as it's not. You could be right, but the fact of the matter is that few really know how much the Trust is worth. It may be worth a lot less due to MNKD, but Al Mann worked a long time throughout the greatest economic baby boom in history while fighting both hot and cold wars before he got into medical devices and philanthropy. Did he only have $1 billion, 1.2, 1.6, 2, or more? How much was pledged? At this point, even $120 million would mean another year for MNKD. Didn't Al sell a research park for around $100 million a few years ago? Didn't Al pull around $100 million back from Purdue? I'm not sure what will happen, and I'm not counting on more Mann dollars. Yet, I won't completely rule it out either now that SNY is gone. Remember that The Mann Group is on the hook for another $30 million plus they were part of the agreement with Deerfield. We don't know what other assets that the trust holds and I would bet that Al was diversified with his assets. So while the MannKind shares are very low he might have shares in some other companies that have done well. Al was a smart man so you can guess that he didn't have everything in one investment that being MannKind.
Hopefully many of us are not just invested in MannKind.
|
|
|
Post by kc on Feb 13, 2017 9:38:11 GMT -5
It takes a quorum of 239,318, 548 shares to vote yes on the proposal. I would assume they know that they have the yes vote.
If the Al Mann Trust holds 203,000,000 shares then I would guess that getting the additional 36,000,000 shares to vote yes will be very easy. Personally I don't see any reason not to vote for the reverse split. The company needs to be as nimble as they can be to work out of this mess.
478,637,095 Outstanding shares 203,000,000 Mann Shares 275,637,095 Balance of shares (100,000,000 of them short)
I guess the company will have a true accounting of the shares when they see the vote and know who voted and where the shares were held.
|
|
|
Post by kc on Feb 13, 2017 9:36:17 GMT -5
The good thing for us is that the trust owns common shares and not preferred shares. Common shares are treated the same in a bankruptcy proceeding they become worthless. Where preferred shares are still valuable. So the Mann Foundation is in the same situation as we are as common shareholders.
|
|
|
Post by kc on Feb 11, 2017 12:22:18 GMT -5
Interesting thought. Low is the symbol for mission from a website on over the counter insulin. It seems that most of the insulin sold today is designer insulin that requires serious dosing and prescription information. Afrezza being just a human insulin might fit that particular niche for being an over-the-counter product. That would be an easy for T2 diabetics. insulinnation.com/treatment/medicine-drugs/insulin-over-counter/
|
|
|
Post by kc on Feb 11, 2017 9:44:18 GMT -5
I don't believe that anybody here is giving any pie in the sky comments. I think we are all very realistic that we have a bad hand. But the management team has worked diligently to work their way to a better hand. It will not happen overnight so we need to just sit back and hope that they play the right cards.
|
|
|
Post by kc on Feb 11, 2017 8:28:58 GMT -5
Falconquest get over it. You keep repeating the same negative crap.
|
|
|
Post by kc on Feb 11, 2017 7:55:08 GMT -5
What do you mean without a R/S? They are going to do it, most likely a 10:1. They are not positively going to do it.. They might do it if it is required to keep from delisting. They still may get a 180 day extension so the Split would not be needed. Also there could be a positive news event that could send the share price above the 1.00 mark for 10 consecutive days which again would result in not needing to do a reverse split. I personally think Matt is only being cautious in having a reverse split approved just in case it was needed to do so. its a tool to have at his disposal just encase and he would be negligent if he was not prepared. I'm sure the board met and recommended to be safe. Well stated. The positive event of a turn around is getting approval by NASDAQ of the plan for a reverse split that never has to take place. The seeds for a turnaround have firmly planted in the ground And will begin sprouting in the spring and summer. It is actually remarkable what the management team has accomplished in less than 12 months. Sure we would like to of seen rapid sales and rising PPS, But the fact is this is a newly reborn company and success will not happen overnight.
|
|
|
Post by kc on Feb 10, 2017 21:20:09 GMT -5
Liane, That was an amazing story. If you know Dr. Davidson you ashould write to him and tell him about MannKind and Afrezza. He sounds like the type of guy who is very open minded to learn more about the great insulin product. Perhaps you might convince him to contact Dr. Urbanski as that would be the type of Doctor Who MannKind would like to engage with in a pediatric study.
We also should check out that website you might even find they have discussed Afrezza there.
Great story about parents taking action to help their kids through their diabetes problems. It's a life or death situation and I commend those parents.
Here is a link on his video biography:
|
|
|
Post by kc on Feb 10, 2017 15:30:19 GMT -5
So sad to see the markets soaring, new highs established, and MNKD languishing in the bowels of the forgotten. I also noticed short interest increased by two million...perhaps those who have lent shares out, received dividends, purchased additional shares, and lent the out as well. I've read posts about the pros and cons of a reverse split, the whys and why nots of TV ads, and how the company is running out of cash...although they keep hiring at the top end of the scale. I think it was the American Steamboat Co that failed to turn a profit, gave themselves bonuses, and hired a few top execs just before they folded their tent leaving stockholders holding the bag. I'm seeing a trend along those lines with MNKD...no sales, no revenue, reverse split on the horizon, hiring Amgen execs, and promising a turnaround any time now. I still keep my fingers crossed for a miracle and remind myself why I bought this stock in the first place. Like the Cubs and Red Sox after long droughts and saying 'maybe next year,' their ship finally came in. I just hope I'm still alive to see MNKD's ship come in. One day MannKind will be flying high like the market is today. Until then I am thankful that my other investments are flying upwards it takes the pressure off of my MannKind investment.
|
|
|
Post by kc on Feb 10, 2017 13:08:28 GMT -5
quote; A drug is "prescription only" when medical professionals must supervise its use because patients are not able to use the drug safely on their own.
Reply: I do not know any medical physician giving/ injecting or inserting/ setting up/filling and putting in the data on pumps for diabetics.
Diabetics ARE their own supervisors. And safety with subq fast acting insulin? what safety?
Everything you said. Peppy! The disconnect between prescription and physician involvement in treatment and reality IS HUGE! Patients manage their own risk and for better or worse the clinic has essentially little control over those risks. Otherwise there would be more "compliance" (wrong word since patients try their best with Gaussian distribution of results and outcomes). I can maybe understand controlling liquid insulin since it could be used for nefarious purposes (dont ask me to explain- you'd have to kill me if I told you)but.... But Afrezza could be sold from the shelves, and should be since it is totally customizable and no one is going to "accidentally" overdose an innocent bystander ala cloak and dagger mystery...
Now that would be a novel idea Afrezza over they counter since its not an injectable insulin product.
|
|
|
Post by kc on Feb 10, 2017 12:53:58 GMT -5
All i think about when i hear all of the restrictions and how MNKD can't say stuff is all the adds i see for drugs that have 9M warnings about the side effects. When i hear it i think, how can people even consider this stuff, yet there it is on TV and i'm sure lots of people are hearing it and enough are buying it. <headscratch> That is the problem with buying TV advertising. They have to according to the FDA list all the contradictions of taking the drug. It waste's a lot of valuable air time. MannKind would be smart to use Facebook advertising targeted to diabetics. That way the length of the ad could be whatever time it took to state the indications and contradictions. The have started that with some twitter ads and I would guess they will use some pay per clicks but they need a real advertisement campaign.
I also thought that they could do an infomercial on Afrezza, What its about, how to use it and also they contradictions. Infomercials could be purchased fairly cheaply on weird day parts on some cable networks. They don't have to have a high production value as much as just providing information. They also could have that infomercial on their web site and use for a pay click campaign. I am sure the cost to produce would be cheap and they don't have to get to overly technical.
|
|
|
Post by kc on Feb 9, 2017 10:38:23 GMT -5
Give Matt credit? Hell no. Why were they financially running on fumes? Where was brilliant Matt as they didn't raise cash when the share price was high.....so that Mannkind could weather the storm if Sanofi bailed. No, instead MNKD had no foresight and later raised cash at $1 or less a share. The entire BOD should be thrown out for mismanagement IMO. So who are you going to replace the BOD and management with? Who controls the stock to vote on the BOD and Management? think about what you say in anger or jest.
|
|
|
Post by kc on Feb 8, 2017 14:17:00 GMT -5
as we arrive at the magic $0.50pps----now just hold that pps MNKD until 2/24. This would take us from 500mm outstanding shares to 50mm shares.... pretty close to the IPO. Sure makes one wonder who is the primary manipulator of MNKD does it not? MNKD had best make some very important/positive announcements once we go to $5.00ps after the R/S or we will be ripped off & down in days. Maybe that position of strength Matt spoke about refers to the master plan materializing post R/S? I apologize for investing in this folks....it I had not it would be $50.00 by now. There is no master plan. Remember, it's Matt we are talking about. Matt. Actually for a cash strapped company they have moved mountains over the last 12 months. Perhaps we are shell shocked as we have seen the PPS go down to nothing but think about how hard it must be to tell the story to new hire's that your trying to bring on board to right the company. The on boarding is a monumental task. Then you have to convince the doctors that you are here to stay in the marketplace. In my opinion we should give him and the team some slack as they all know that its going to be easier for the company to fail then it is to move forward. It really sucks to be Matt....
In 12 months look at how far we have traveled to get to this weeks sales training in Las Vegas.
|
|